Corvus Pharmaceuticals Inc sell tbackenh
Start price
20.09.21
/
60%
€5.20
Target price
20.09.22
€4.00
Performance (%)
-22.69%
End price
22.10.21
€4.02
Summary
This prediction ended on 22.10.21 with a price of €4.02. The prediction for Corvus Pharmaceuticals Inc closed with a convincing performance of -22.69%. tbackenh has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | -2.413% | -2.413% | 36.931% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% |
According to tbackenh what are the pros and cons of Corvus Pharmaceuticals Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
Cons
Comments by tbackenh for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Sell mit Kursziel 13,0
Kursziel geändert auf 4,0